Selective Serotonin Reuptake Inhibitors and Risk of Serotonin Syndrome as Consequence of Drug-Drug Interactions: analysis of The FDA Adverse Event Reporting System (FAERS).  Novella A, Elli C, Pasina L.  Med Princ Pract. 2025 Apr 25:1-12…

Risk of adverse obstetrical and neonatal outcomes in women consuming recreational drugs during pregnancy.  Kandhasamy, S., Lepigeon, K., Baggio, S. et al. BMC Pregnancy Childbirth 25, 456 (2025). doi.org/10.1186/s12884-024-07062-1…

Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001-22, New South Wales, Australia.  Jones N, Ghouse FN, Gibson A, Tran DT, Santo T Jr, Bharat C, Farrell M, Degenhardt L.  Int J Epidemiol. 2025…

Data Resource Profile Update: The Opioid Agonist Treatment and Safety II (OATS II) Study, 2001-22, New South Wales, Australia.  Jones N, Ghouse FN, Gibson A, Tran DT, Santo T Jr, Bharat C, Farrell M, Degenhardt L.  Int J Epidemiol. 2025…

Distributed Opioids in Morphine Equivalent: A Global Measure of Availability for Palliative Care. Knaul FM, Arreola-Ornelas H, Kwete XJ, Bhadelia A, Berterame S, Connor SR, De Lima L, Downing J, Krakauer EL, Méndez-Carniado O, Pastrana T, Pérez-Cru…

Comprehensive Care for People Who Use Drugs: Combining Infectious Diseases Services, Harm Reduction, and Primary Care.  Knodle RD, Messmer SE, Murphy AL, Smith RO, Huyck M, Cotler K, Jimenez AD, Mayer SM.  Open Forum Infect Dis. 2025 Apr…